Voyageur Pharmaceuticals Overview

  • Founded
  • 2008
Founded
  • Status
  • Public
  • Stock Symbol
  • VM
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $0.08
  • (As of Monday Closing)

Voyageur Pharmaceuticals General Information

Description

Voyageur Pharmaceuticals Ltd is engaged in the development of pharmaceutical ingredients (API) minerals. The company focuses on developing barium and iodine radiocontrast products and bromine based pharmaceutical products. It provides its products to medical applications and diagnostics.

Contact Information

Formerly Known As
Voyageur Minerals
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Metals, Minerals and Mining
Stock Exchange
TSX
Primary Office
  • 339 50th Avenue South East
  • Suite 255
  • Calgary, Alberta T2G 2B3
  • Canada
+1 (403) 000-0000

Voyageur Pharmaceuticals Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Voyageur Pharmaceuticals Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.08 $0.08 $0.03 - $0.28 $8.04M 102M 55.1K -$0.02

Voyageur Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 31-Aug-2021 FY 2020 30-Nov-2020 FY 2019 30-Nov-2019 FY 2018 30-Nov-2018
EV 6,633 2,357 3,655 3,538
Revenue 0 0 0 0
EBITDA (1,555) (846) (414) (431)
Net Income (1,555) (847) (415) (431)
Total Assets 2,418 982 1,209 954
Total Debt 40 207 104 135
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Voyageur Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Voyageur Pharmaceuticals‘s full profile, request access.

Request a free trial

Voyageur Pharmaceuticals Executive Team (5)

Name Title Board Seat Contact Info
Brent Willis Chief Executive Officer & Board Member
Gordon Forbes Chief Financial Officer
Ron Love Chief Financial Officer
Bradley Willis Board Member & Founder
You’re viewing 4 of 5 executive team members. Get the full list »

Voyageur Pharmaceuticals Board Members (6)

Name Representing Role Since
0000000 000000 Voyageur Pharmaceuticals Board Member & Founder 000 0000
00000 000000 Voyageur Pharmaceuticals Chief Executive Officer & Board Member 000 0000
0000000 0000000000 Voyageur Pharmaceuticals Board Member 000 0000
00000 00000 Voyageur Pharmaceuticals Board Member 000 0000
You’re viewing 4 of 6 board members. Get the full list »

Voyageur Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Voyageur Pharmaceuticals‘s full profile, request access.

Request a free trial

Voyageur Pharmaceuticals Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 09-Jan-2019 00000 0000 Specialty Chemicals
00000000 0000 20-Mar-2018 00000 0000 Other Metals, Minerals and Mining 0000 0000
Golden Sun Capital 02-Mar-2017 Merger/Acquisition Other Financial Services 0000 0000
To view Voyageur Pharmaceuticals’s complete investments and acquisitions history, request access »